Clinical trial NCT03239431 - References

Asthma — A Study to Determine the Clinical Characteristics, Comorbidities, Treatment Status and Exacerbations of Asthma Patients

Citation(s)

•   Bai TR, Vonk JM, Postma DS, Boezen HM
  Severe exacerbations predict excess lung function decline in asthma. Eur Respir J. 2007 Sep;30(3):452-6. Epub 2007 May 30.
•   Boulet LP
  Influence of comorbid conditions on asthma. Eur Respir J. 2009 Apr;33(4):897-906. doi: 10.1183/09031936.00121308. Review.
•   Bousquet J, Clark TJ, Hurd S, Khaltaev N, Lenfant C, O'byrne P, Sheffer A
  GINA guidelines on asthma and beyond. Allergy. 2007 Feb;62(2):102-12. Review.
•   Dexheimer JW, Borycki EM, Chiu KW, Johnson KB, Aronsky D
  A systematic review of the implementation and impact of asthma protocols. BMC Med Inform Decis Mak. 2014 Sep 9;14:82. doi: 10.1186/1472-6947-14-82.
•   Engelkes M, Janssens HM, de Jongste JC, Sturkenboom MC, Verhamme KM
  Medication adherence and the risk of severe asthma exacerbations: a systematic review. Eur Respir J. 2015 Feb;45(2):396-407. doi: 10.1183/09031936.00075614. Epub 2014 Oct 16. Review.
•   Guarnaccia S, Lombardi A, Gaffurini A, Chiarini M, Domenighini S, D'Agata E, Schumacher RF, Spiazzi R, Notarangelo LD
  Application and implementation of the GINA asthma guidelines by specialist and primary care physicians: a longitudinal follow-up study on 264 children. Prim Care Respir J. 2007 Dec;16(6):357-62.
•   Heaney LG, Conway E, Kelly C, Johnston BT, English C, Stevenson M, Gamble J
  Predictors of therapy resistant asthma: outcome of a systematic evaluation protocol. Thorax. 2003 Jul;58(7):561-6.
•   Hekking PP, Wener RR, Amelink M, Zwinderman AH, Bouvy ML, Bel EH
  The prevalence of severe refractory asthma. J Allergy Clin Immunol. 2015 Apr;135(4):896-902. doi: 10.1016/j.jaci.2014.08.042. Epub 2014 Oct 16.
•   Ko FW, Lai CK, Woo J, Ho SC, Ho CW, Goggins W, Hui DS
  12-year change in prevalence of respiratory symptoms in elderly Chinese living in Hong Kong. Respir Med. 2006 Sep;100(9):1598-607. Epub 2006 Jan 30.
•   Koga T, Oshita Y, Kamimura T, Koga H, Aizawa H
  Characterisation of patients with frequent exacerbation of asthma. Respir Med. 2006 Feb;100(2):273-8. Epub 2005 Jul 5.
•   Luskin AT, Chipps BE, Rasouliyan L, Miller DP, Haselkorn T, Dorenbaum A
  Impact of asthma exacerbations and asthma triggers on asthma-related quality of life in patients with severe or difficult-to-treat asthma. J Allergy Clin Immunol Pract. 2014 Sep-Oct;2(5):544-52.e1-2. doi: 10.1016/j.jaip.2014.02.011. Epub 2014 Jul 3.
•   Miller MK, Lee JH, Miller DP, Wenzel SE; TENOR Study Group
  Recent asthma exacerbations: a key predictor of future exacerbations. Respir Med. 2007 Mar;101(3):481-9. Epub 2006 Aug 17.
•   Moorman JE, Akinbami LJ, Bailey CM, Zahran HS, King ME, Johnson CA, Liu X
  National surveillance of asthma: United States, 2001-2010. Vital Health Stat 3. 2012 Nov;(35):1-58.
•   Nestor A, Calhoun AC, Dickson M, Kalik CA
  Cross-sectional analysis of the relationship between national guideline recommended asthma drug therapy and emergency/hospital use within a managed care population. Ann Allergy Asthma Immunol. 1998 Oct;81(4):327-30.
•   O'Byrne PM, Pedersen S, Lamm CJ, Tan WC, Busse WW; START Investigators Group
  Severe exacerbations and decline in lung function in asthma. Am J Respir Crit Care Med. 2009 Jan 1;179(1):19-24. doi: 10.1164/rccm.200807-1126OC. Epub 2008 Oct 31. Erratum in: Am J Respir Crit Care Med. 2010 Oct 1;182(7):983-4.
•   Pasha MA, Sundquist B, Townley R
  Asthma pathogenesis, diagnosis, and management in the elderly. Allergy Asthma Proc. 2017 May 1;38(3):184-191. doi: 10.2500/aap.2017.38.4048. Review.
•   Robinson DS, Campbell DA, Durham SR, Pfeffer J, Barnes PJ, Chung KF; Asthma and Allergy Research Group of the National Heart and Lung Institute
  Systematic assessment of difficult-to-treat asthma. Eur Respir J. 2003 Sep;22(3):478-83.
•   Scribano PV, Lerer T, Kennedy D, Cloutier MM
  Provider adherence to a clinical practice guideline for acute asthma in a pediatric emergency department. Acad Emerg Med. 2001 Dec;8(12):1147-52.
•   Serrano-Pariente J, Plaza V
  Near-fatal asthma: a heterogeneous clinical entity. Curr Opin Allergy Clin Immunol. 2017 Feb;17(1):28-35. doi: 10.1097/ACI.0000000000000333. Review.
•   Shiffman RN, Freudigman Md, Brandt CA, Liaw Y, Navedo DD
  A guideline implementation system using handheld computers for office management of asthma: effects on adherence and patient outcomes. Pediatrics. 2000 Apr;105(4 Pt 1):767-73.
•   Sullivan PW, Slejko JF, Ghushchyan VH, Sucher B, Globe DR, Lin SL, Globe G
  The relationship between asthma, asthma control and economic outcomes in the United States. J Asthma. 2014 Sep;51(7):769-78. doi: 10.3109/02770903.2014.906607. Epub 2014 Apr 7.
•   Tay TR, Radhakrishna N, Hore-Lacy F, Smith C, Hoy R, Dabscheck E, Hew M
  Comorbidities in difficult asthma are independent risk factors for frequent exacerbations, poor control and diminished quality of life. Respirology. 2016 Nov;21(8):1384-1390. doi: 10.1111/resp.12838. Epub 2016 Jul 1.
•   ten Brinke A, Sterk PJ, Masclee AA, Spinhoven P, Schmidt JT, Zwinderman AH, Rabe KF, Bel EH
  Risk factors of frequent exacerbations in difficult-to-treat asthma. Eur Respir J. 2005 Nov;26(5):812-8.
•   Turner MO, Noertjojo K, Vedal S, Bai T, Crump S, Fitzgerald JM
  Risk factors for near-fatal asthma. A case-control study in hospitalized patients with asthma. Am J Respir Crit Care Med. 1998 Jun;157(6 Pt 1):1804-9.
•   Williams LK, Peterson EL, Wells K, Ahmedani BK, Kumar R, Burchard EG, Chowdhry VK, Favro D, Lanfear DE, Pladevall M
  Quantifying the proportion of severe asthma exacerbations attributable to inhaled corticosteroid nonadherence. J Allergy Clin Immunol. 2011 Dec;128(6):1185-1191.e2. doi: 10.1016/j.jaci.2011.09.011. Epub 2011 Oct 21.
•   Wong GW, Leung TF, Ko FW
  Changing prevalence of allergic diseases in the Asia-pacific region. Allergy Asthma Immunol Res. 2013 Sep;5(5):251-7. doi: 10.4168/aair.2013.5.5.251. Epub 2013 Mar 18. Review.

A 3 Year Longitudinal Study of the Level of Asthma Control and Treatment of Asthma Patients in Hong Kong

Details for clinical trial NCT03239431